Related Experiment Video
Updated: Apr 16, 2026

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins
Published on: August 9, 2019
The cell cycle regulator CCDC6 is a key target of RNA-binding protein EWS
Sujitha Duggimpudi1, Erik Larsson2, Schafiq Nabhani1
1Department of Pediatric Oncology, Hematology and Clinical Immunology, Center for Child and Adolescent Health, Heinrich Heine University, Medical Faculty, Duesseldorf, Germany.
Abstract:
Genetic translocation of EWSR1 to ETS transcription factor coding region is considered as primary cause for Ewing sarcoma. Previous studies focused on the biology of chimeric transcription factors formed due to this translocation. However, the physiological consequences of heterozygous EWSR1 loss in these tumors have largely remained elusive. Previously, we have identified various mRNAs bound to EWS using PAR-CLIP. In this study, we demonstrate CCDC6, a known cell cycle regulator protein, as a novel target regulated by EWS. siRNA mediated down regulation of EWS caused an elevated apoptosis in cells in a CCDC6-dependant manner. This effect was rescued upon re-expression of CCDC6. This study provides evidence for a novel functional link through which wild-type EWS operates in a target-dependant manner in Ewing sarcoma.
Insights
Ewing sarcoma involves EWSR1 gene translocations. This study reveals wild-type EWSR1 regulates cell cycle protein CCDC6, impacting apoptosis, offering new therapeutic insights.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Ewing sarcoma is primarily caused by EWSR1 gene translocations fusing it with ETS transcription factors.
- Research has focused on the chimeric proteins, but the role of wild-type EWSR1 loss remains unclear.
- Previous work identified messenger RNAs (mRNAs) bound by the EWS protein using Photoactivatable-Ribonucleoside-Enhanced Crosslinking and Immunoprecipitation (PAR-CLIP).
Purpose of the Study:
- To investigate the physiological consequences of heterozygous EWSR1 loss in Ewing sarcoma.
- To identify novel targets regulated by the wild-type EWS protein.
- To elucidate the functional role of EWS in Ewing sarcoma pathogenesis.
Main Methods:
- Utilized previously generated PAR-CLIP data to identify EWS-bound mRNAs.
- Employed small interfering RNA (siRNA) to downregulate EWS expression.
- Assessed apoptosis levels and performed rescue experiments by re-expressing CCDC6.
Main Results:
- Identified CCDC6, a known cell cycle regulator, as a novel target directly regulated by EWS.
- siRNA-mediated knockdown of EWS led to increased apoptosis in cancer cells.
- The pro-apoptotic effect of EWS downregulation was dependent on CCDC6 levels and could be rescued by CCDC6 re-expression.
Conclusions:
- Wild-type EWS plays a crucial role in Ewing sarcoma by regulating the cell cycle through CCDC6.
- EWS exerts its function in a target-dependent manner, highlighting CCDC6 as a key mediator.
- This study uncovers a novel mechanism of EWS function and suggests potential therapeutic strategies targeting the EWS-CCDC6 axis.
Related Concept Videos
Transcription Initiation
The promoters and enhancers and their accessory proteins allow tight regulation of...
Eukaryotic RNA Polymerases
All three eukaryotic RNAPs require specific transcription factors, of which the...
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
Cis-regulatory Sequences
Cis-regulatory Sequences
Cooperative Binding of Transcription Regulators

